Revolade 25mg Tablets: Price, Uses, Dosage, Instructions, Side

website revolade Revolade pCPA File Number: 20760 Negotiation Status: Negotiations were not pursued Indication: Thrombocytopenia associated revolade Revolade est indiqué chez les patients adultes présentant une aplasie médullaire acquise sévère qui sont soit réfractaires à un traitement

revolade Revolade 50 Tablet Information Revolade 50 Tablet is a commercial drug that is prescribed in the form of Tablet It is primarily used for the treatment of  Revolade Tablet 25 mg is a product of Novartis Ltd Its generic name is Eltrombopag Olamine   Revolade Tablet contains Eltrombopag, a thrombopoietin receptor agonist used to treat low blood platelet counts Megakaryocytes, large bone

Share

Share

Link

Turn off sharing Copy link

See all details